Clinical Effects of Brain Machine Interface in Chronic Stroke Patient

Sponsor
National Rehabilitation Center, Seoul, Korea (Other)
Overall Status
Unknown status
CT.gov ID
NCT04451941
Collaborator
(none)
30
1
2
18
1.7

Study Details

Study Description

Brief Summary

Determination of clinical effects of brain machine interface in chronic stroke patient without wrist extensor strength

Condition or Disease Intervention/Treatment Phase
  • Device: Experimental: RecoveriX with individual EEG calibration
  • Device: RecoveriX without individual EEG calibration
N/A

Detailed Description

The purpose of this study is to compare RecoveriX with individual EEG calibration and without individual EEG calibration to determine the clinical effect of brain machine interface in chronic stroke patient without wrist extensor strength

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Determination of Clinical Effects of Brain Machine Interface in Chronic Stroke Patient Without Wrist Extensor Strength
Actual Study Start Date :
Jul 1, 2020
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: RecoveriX with individual EEG calibration

RecoveriX applied functional electrical stimulation (FES) according to individual brainwave by individual EEG calibration for 4 weeks

Device: Experimental: RecoveriX with individual EEG calibration
RecoveriX applied FES according to individual brainwave by individual EEG calibration for 5 times a week for 4 weeks

Sham Comparator: RecoveriX without individual EEG calibration

RecoveriX applied FES according to the brainwave of other subjects regardless of the individual brainwave for 4 weeks

Device: RecoveriX without individual EEG calibration
RecoveriX applied FES according to the brainwave of other subjects regardless of the individual brainwave for 5 times a week for 4 weeks

Outcome Measures

Primary Outcome Measures

  1. Fugl-Meyer Assessment - upper extremity [4 weeks after baseline]

    Fugl-Meyer Assessment is indicator of the level of impairment of upper extremity, with higher scores indicating lower impairment. Total scores range from 0 to 66, each item being scored on a 3-point scale (0, cannot perform; 1, partially performs; and 2, fully performs the task).

Secondary Outcome Measures

  1. Box and block test [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    Box and block test measures unilateral gross manual dexterity. Higher scores indicate better gross manual dexterity.

  2. Jebsen hand function test [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    Jebsen hand function test provides a standardized and objective evaluation of fine and gross motor hand function using simulated activities of daily living. Total score is the sum of time taken for each subtest, which are rounded to the nearest second. Shorter times indicate better performance.

  3. 9-hole peg test [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    9-hole peg test measures finger dexterity in patients with stroke. Scores are based on the time taken to complete the test activity, recorded in seconds.

  4. Medical Research Council (MRC) scale of affected upper extremity [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    The MRC is a standardized set of assessments that measure muscle strength and function. The MRC scale of muscle strength uses a score of 0 to 5 to grade the power of a particular muscle group in relation to the movement of a single joint.

  5. Joint position sense [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    Joint position sense is tested by holding the most distal joint of a digit by its sides and moving it slightly up or down. First, demonstrate the test with the patient watching so they understand what is wanted then perform the test with their eyes closed.

  6. Sensation of limb movement [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    For the ability to sense a sharp object, the best screening test uses a safety pin or other sharp object to lightly prick the face, torso, and 4 limbs; the patient is asked whether the pinprick feels the same on both sides and whether the sensation is dull or sharp.

  7. active range of motion (AROM) of wrist flexion/extension [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    active range of motion of wrist flexion and extension

  8. Modified Ashworth scale [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    Modified Ashworth scale measures resistance during passive soft-tissue stretching. Scores range from 0-4, with 5 choices. A score of 1 indicates no resistance, and 5 indicates rigidity.

  9. Stroke impact scale [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    Stroke impact scale evaluates how stroke has impacted your health and life. Each item is rated in a 5-point Likert scale in terms of the difficulty the patient has experienced in completing each item. Summative scores are generated for each domain, scores range from 0-100.

  10. electroencephalography (EEG) effective connectivity [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    EEG effective connectivity describes the causal influences that neural units exert over another.

  11. Stroke rehabilitation motivation scale [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    Stroke rehabilitation motivation scale includes 28 items applicable to stroke rehabilitation, adapted from the Sports Motivation Scale. The response to each item is measured on a scale of 1 to 5. Higher score indicates higher rehabilitation motivation level for all items, except three reverse evaluation items (items #5, #12, and #23), for which a higher score indicates lower motivation level.

  12. Intrinsic motivation inventory [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    The Intrinsic Motivation Inventory assesses participants' interest/enjoyment, perceived competence, effort, value/usefulness, felt pressure and tension, and perceived choice while performing a given activity, thus yielding six subscale scores. A higher score will indicate more of the concept described in the subscale name.

  13. Motor evoked potential [baseline, 2 weeks after baseline, 4 weeks after baseline, 8 weeks after baseline]

    action potential elicited by noninvasive stimulation of the motor cortex through the scalp

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hemiplegic patients secondary to first cerebrovascular accidents

  • Weak wrist extension

  • Onset ≥ 6 months

  • Fugl-Meyer Assessment score ≥ 19

  • Cognitively intact enough to understand and follow the instructions from the investigator

Exclusion Criteria:
  • Wrist extensor spasticity above or modified ashworth scale 2

  • Severe upper extremity pain that could interfere with rehabilitation therapy

  • Neurological disorders other than stroke that can cause motor deficits

  • Uncontrolled severe medical conditions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Rehabilitation Center Seoul Korea, Republic of 142884

Sponsors and Collaborators

  • National Rehabilitation Center, Seoul, Korea

Investigators

  • Principal Investigator: Joon-Ho Shin, National Rehabilitation Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joon-Ho Shin, Chief of Brain Injury Rehabilitation Department, Principal Investigator, National Rehabilitation Center, Seoul, Korea
ClinicalTrials.gov Identifier:
NCT04451941
Other Study ID Numbers:
  • NRC-2020-01-007
First Posted:
Jun 30, 2020
Last Update Posted:
Jul 31, 2020
Last Verified:
Jul 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joon-Ho Shin, Chief of Brain Injury Rehabilitation Department, Principal Investigator, National Rehabilitation Center, Seoul, Korea
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 31, 2020